Grants and Contributions:
Title:
Development of virtual patient-stratification biomarker assays
Agreement Number:
1032059
Agreement Value:
$150,000.00
Agreement Date:
Jun 16, 2025 - Aug 31, 2026
Description:
The project aims to develop virtual biomarkers using machine learning (ML) to aid in subtyping lung cancers and stratifying breast cancer patients.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Vancouver, British Columbia, CA V6C 0A3
Reference Number:
172-2025-2026-Q1-1032059
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
734771603
Recipient Type:
For-profit organization
Recipient's Operating Name:
ViewsML Technologies Inc.
Recipient's Legal Name:
ViewsML Technologies Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710